Our Sponsors
Website http://www.complianceonline.com/ecommerce/control/seminar?product_id=80006SEM&?channel=ourglocal |
Edit Freely
Category FDA requirements; OOS Investigations; CAPAs; Equipment Qualification; Biologics Stability Programs; ICH; WHO; Stability methods; GMP systems; Pharma GMP system; Biotech GMP system
Deadline: May 10, 2012 | Date: May 11, 2012-May 12, 2012
Venue/Country: Boston, U.S.A
Updated: 2012-03-28 18:45:14 (GMT+9)
The FDA has ramped up surveillance and we have seen an increase in the number of warning letters issued to manufacturers. We have seen a corresponding increase in GMP upgrade projects in the industry.
This workshop will provide the audience with information to perform a gap analysis of their existing GMP systems by reviewing the major areas of concern listed by FDA inspectors. The systems covered will include FDA requirements for OOS Investigations, Pharmaceutical and Biologics Stability Programs and Method Validation and Handling Regulatory Inspections.
Who will Benefit- QC chemists, supervisors and managers- R&D chemists, supervisors and managers- QA Managers and personnel- Regulatory Affairs personnelKeywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.